Eli Lilly's direct-to-patient platform for buying its own branded medications (such as Zepbound and Mounjaro), sometimes including self-pay vial options at lower prices than the list price. It's a manufacturer channel, not a compounding service. The product is the authentic, FDA-approved drug. Several telehealth providers integrate with it to fulfill brand-name prescriptions.
Related terms: NovoCare · Branded drug · Copay card / manufacturer savings program · Zepbound